177 related articles for article (PubMed ID: 33361334)
21. Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs.
Gemechu Y; Millrine D; Hashimoto S; Prakash J; Sanchenkova K; Metwally H; Gyanu P; Kang S; Kishimoto T
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11802-11807. PubMed ID: 30373817
[TBL] [Abstract][Full Text] [Related]
22. USP15 antagonizes CRL4
Nguyen TV
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
[TBL] [Abstract][Full Text] [Related]
23. Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Wang X; Qin G; Liang X; Wang W; Wang Z; Liao D; Zhong L; Zhang R; Zeng YX; Wu Y; Kang T
Nat Commun; 2020 Feb; 11(1):1141. PubMed ID: 32111827
[TBL] [Abstract][Full Text] [Related]
24. The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma.
Heider M; Eichner R; Stroh J; Morath V; Kuisl A; Zecha J; Lawatscheck J; Baek K; Garz AK; Rudelius M; Deuschle FC; Keller U; Lemeer S; Verbeek M; Götze KS; Skerra A; Weber WA; Buchner J; Schulman BA; Kuster B; Fernández-Sáiz V; Bassermann F
Mol Cell; 2021 Mar; 81(6):1170-1186.e10. PubMed ID: 33571422
[TBL] [Abstract][Full Text] [Related]
25. Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.
Li B; Orton D; Neitzel LR; Astudillo L; Shen C; Long J; Chen X; Kirkbride KC; Doundoulakis T; Guerra ML; Zaias J; Fei DL; Rodriguez-Blanco J; Thorne C; Wang Z; Jin K; Nguyen DM; Sands LR; Marchetti F; Abreu MT; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
Sci Signal; 2017 Jun; 10(485):. PubMed ID: 28655862
[TBL] [Abstract][Full Text] [Related]
26. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
[TBL] [Abstract][Full Text] [Related]
27. Exploiting the MDM2-CK1α protein-protein interface to develop novel biologics that induce UBL-kinase-modification and inhibit cell growth.
Huart AS; MacLaine NJ; Narayan V; Hupp TR
PLoS One; 2012; 7(8):e43391. PubMed ID: 22916255
[TBL] [Abstract][Full Text] [Related]
28. Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.
Krönke J; Fink EC; Hollenbach PW; MacBeth KJ; Hurst SN; Udeshi ND; Chamberlain PP; Mani DR; Man HW; Gandhi AK; Svinkina T; Schneider RK; McConkey M; Järås M; Griffiths E; Wetzler M; Bullinger L; Cathers BE; Carr SA; Chopra R; Ebert BL
Nature; 2015 Jul; 523(7559):183-188. PubMed ID: 26131937
[TBL] [Abstract][Full Text] [Related]
29. Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.
Li Q; Li Y; Gu B; Fang L; Zhou P; Bao S; Huang L; Dai X
J Biol Chem; 2015 Aug; 290(35):21553-67. PubMed ID: 26170450
[TBL] [Abstract][Full Text] [Related]
30. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
[TBL] [Abstract][Full Text] [Related]
31. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways.
Hideshima T; Ogiya D; Liu J; Harada T; Kurata K; Bae J; Massefski W; Anderson KC
Leukemia; 2021 Jan; 35(1):177-188. PubMed ID: 32238854
[TBL] [Abstract][Full Text] [Related]
33. Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug-induced thrombocytopenia.
Tochigi T; Miyamoto T; Hatakeyama K; Sakoda T; Ishihara D; Irifune H; Shima T; Kato K; Maeda T; Ito T; Handa H; Akashi K; Kikushige Y
Blood; 2020 Jun; 135(24):2146-2158. PubMed ID: 32219443
[TBL] [Abstract][Full Text] [Related]
34. The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (
Shen C; Li B; Astudillo L; Deutscher MP; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
Biochemistry; 2019 Dec; 58(51):5102-5106. PubMed ID: 31820934
[TBL] [Abstract][Full Text] [Related]
35. CK1α protects WAVE from degradation to regulate cell shape and motility in the immune response.
Hirschhäuser A; van Cann M; Bogdan S
J Cell Sci; 2021 Dec; 134(23):. PubMed ID: 34730182
[TBL] [Abstract][Full Text] [Related]
36. Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.
Borgal L; Rinschen MM; Dafinger C; Liebrecht VI; Abken H; Benzing T; Schermer B
Cell Cycle; 2016; 15(8):1034-45. PubMed ID: 26919559
[TBL] [Abstract][Full Text] [Related]
37. An IMiD-induced SALL4 degron system for selective degradation of target proteins.
Yamanaka S; Shoya Y; Matsuoka S; Nishida-Fukuda H; Shibata N; Sawasaki T
Commun Biol; 2020 Sep; 3(1):515. PubMed ID: 32948804
[TBL] [Abstract][Full Text] [Related]
38. Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis.
Sinnberg T; Menzel M; Kaesler S; Biedermann T; Sauer B; Nahnsen S; Schwarz M; Garbe C; Schittek B
Cancer Res; 2010 Sep; 70(17):6999-7009. PubMed ID: 20699366
[TBL] [Abstract][Full Text] [Related]
39. The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L.
Hao BB; Li XJ; Jia XL; Wang YX; Zhai LH; Li DZ; Liu J; Zhang D; Chen YL; Xu YH; Lee SK; Xu GF; Chen XH; Dang YJ; Liu B; Tan MJ
Acta Pharmacol Sin; 2020 Sep; 41(9):1246-1254. PubMed ID: 32210356
[TBL] [Abstract][Full Text] [Related]
40. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
